comparemela.com

Page 4 - Nick Abbott News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Precigen, Inc (PGEN) CEO Helen Sabzevari on Q2 2022 Results - Earnings Call Transcript

Precigen, Inc. (NASDAQ:NASDAQ:PGEN) Q2 2022 Earnings Conference Call August 08, 2022 04:30 PM ET Company Participants Steven Harasym - Vice President and Head of Investor Relations Helen.

New yorkUnited statesJason butlerBen burnettHarry thomasianHelen sabzevariJennifer kimSteven harasymSteve harasymNick abbottCompany participantsCantor fitzgerald coWells fargo securitiesCantor fitzgeraldDevelopment agreementsPrecigen inc

Zymeworks Inc (ZYME) CEO Ken Galbraith on Q2 2022 Results - Earnings Call Transcript

Zymeworks Inc. (NYSE:NYSE:ZYME) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Jack Spinks - Associate Director of Investor Relations Ken Galbraith - Chair.

France generalNew yorkUnited statesMemorial sloan kettering cancer centerBritish columbiaNew york stock exchangeKen galbraithNeil josephsonPaul mooreStephen willeyAkash tewariKomal jhaveriGena wangCharles zhuNeil klompasAmy li

Gracell Biotechnologies Inc (GRCL) CEO Dr William Cao on Q1 2022 Results - Earnings Call Transcript

Gracell Biotechnologies Inc. (NASDAQ:NASDAQ:GRCL) Q1 2022 Earnings Conference Call May 16, 2022 8:00 a.m.

San diegoUnited statesKevin xieWilliam caoMartina serschJoe catanzaroPiper sandlerKelly shiNick abbottCompany participantsGracell biotechnologies incWells fargoGracell biotechnologiesConference call mayGracell biotechnologies first quarterFirst quarter

IMV Inc (IMV) CEO Andrew Hall on Q1 2022 Results - Earnings Call Transcript

IMV Inc. (NASDAQ:NASDAQ:IMV) Q1 2022 Earnings Conference Call May 13, 2022, 8:00 AM ET Company Participants Andrew Hall – Chief Executive Officer Jeremy Graff – Chief Medical Officer.

United statesNew zealandSan antonioJoseph pantginisAndrew hallMichael baileyBrittany davidsonBrittany davisonPaul stewardsonJoe pantginisJeremy graffBrandon folkesNick abbottCompany participantsImv incHorizon technology finance corporation

Calithera Biosciences (CALA) Q1 2022 Earnings Call Transcript

CALA earnings call for the period ending March 31, 2022.

United statesStephanie wongAydin huseynov ladenburg thalmannCalithera biosciencesSusan molineauxAydin huseynovEmil kuriakoseSwayampakula hc wainwrightSwayampakula ramakanthJonathan changNick abbottAmerican association for cancer researchTakeda pharmaceutical company to calitheraWells fargoMillennium pharmaceuticalsPrivate securities litigation reform act

vimarsana © 2020. All Rights Reserved.